CBD Pet Market Size, Share and Growth Outlook, 2026

CBD Pet Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global CBD Pet Market size is forecast to increase from $589.87 Million in 2026 to $5178.77 Million in 2034 at a CAGR of 31.2% between 2026 and 2034.

The CBD Pet market report provides detailed analysis and outlook of CBD Pet segments including By Product Form (Oils & Tinctures, Edibles & Treats, Capsules & Softgels, Topicals ), By Animal Type (Dogs, Cats, Horses, Other Small Pets ), By Indication (Anxiety & Stress Management, Pain & Inflammation Relief, Epilepsy & Seizure Control, General Wellness & Skin Care), By Distribution Channel (Online, Pet Specialty Stores, Veterinary Clinics & Hospital Pharmacies, Retail Pharmacies & Supermarkets) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

CBD Pet Industry Overview

Regulatory Scrutiny Intensifies Across the CBD Pet Product Landscape

The CBD Pet industry is evolving under increasing regulatory oversight as authorities seek to establish clearer standards for the marketing and distribution of cannabidiol-based animal health products. Regulatory enforcement has become a defining factor shaping product development and commercialization strategies. The U.S. Food and Drug Administration (FDA) issued formal warning letters to several manufacturers promoting unapproved cannabidiol products for animals, emphasizing that CBD products are not recognized as safe or effective under the Federal Food, Drug, and Cosmetic Act. The enforcement actions specifically targeted companies marketing CBD oils, chews, and pellets, including HolistaPet and House of Alchemy, which operates brands such as CBD Dog Health, Hamet & Love, and MycoDog. The FDA also expressed significant concern regarding the sale of unapproved CBD products intended for food-producing animals and requested the immediate cessation of these unverified distributions. These regulatory developments are prompting companies to strengthen compliance practices and reevaluate product positioning within the companion animal wellness sector.

Functional Multi-Ingredient Formulations Redefine Product Innovation

Product innovation within the CBD Pet market is increasingly moving beyond traditional single-ingredient cannabidiol supplements toward scientifically formulated multifunctional wellness products. A comprehensive review of commercial innovation trends and utility patents in the pet care sector highlights a major shift toward integrated formulations that combine CBD with complementary bioactive ingredients. Manufacturers are incorporating gastrointestinal support compounds, immune health ingredients, cognitive wellness nutrients, and botanical extracts alongside cannabidiol to create broader functional pet nutrition products. This trend reflects industry efforts to address regulatory scrutiny surrounding therapeutic claims while providing measurable physiological benefits through functional pet foods. By combining CBD with multiple health-supporting ingredients, companies are positioning products within preventive wellness and nutritional support categories rather than solely therapeutic applications.

Advanced Drug Delivery Technologies Improve Veterinary CBD Administration

Research and development efforts are also focused on overcoming longstanding challenges associated with cannabidiol administration in veterinary medicine. One of the primary limitations of oral CBD therapies has been poor bioavailability and the need for frequent dosing, which can reduce treatment compliance among pet owners. To address these challenges, researchers have successfully developed a sustained-release CBD delivery platform utilizing poly(lactic-co-glycolic acid) (PLGA) microspheres and a functional alternative matrix. In preclinical evaluations, the injectable system demonstrated safe, controlled, and uniform CBD release over a 20-day period. This long-acting delivery approach establishes a potential pathway for less frequent administration while maintaining therapeutic effectiveness in animal anti-inflammatory applications. The emergence of advanced drug delivery systems highlights the industry's growing focus on improving efficacy, convenience, and clinical utility of cannabidiol-based veterinary products.

CBD Pet Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global CBD Pet market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Honest Paws, Canna-Pet, Pet Releaf, HolistaPet, Charlotte's Web (Paw Choice), cbdMD, Inc. (Paw CBD), Canopy Growth Corporation (Martha Stewart CBD for Pets), Wet Noses, Joy Organics, Fomo Bones. The CBD Pet market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the CBD Pet industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth CBD Pet Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by CBD Pet companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional CBD Pet markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

CBD Pet Market Competitive Benchmarking and Company Analysis

Leading companies in CBD Pet industry include- Honest Paws, Canna-Pet, Pet Releaf, HolistaPet, Charlotte's Web (Paw Choice), cbdMD, Inc. (Paw CBD), Canopy Growth Corporation (Martha Stewart CBD for Pets), Wet Noses, Joy Organics, Fomo Bones. The CBD Pet market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US CBD Pet Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the CBD Pet market remains one of the strongest-performing segments in the country.
The US CBD Pet Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US CBD Pet market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across CBD Pet industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian CBD Pet markets

Canada's strong CBD Pet sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian CBD Pet market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany CBD Pet Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest CBD Pet market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of CBD Pet population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany CBD Pet industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the CBD Pet market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support CBD Pet sales through 2034

France CBD Pet companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK CBD Pet Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of CBD Pet distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China CBD Pet Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China CBD Pet market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of CBD Pet industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese CBD Pet industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India CBD Pet Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian CBD Pet market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil CBD Pet market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa CBD Pet Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

CBD Pet Market Segmentation

By Product Form
Oils & Tinctures
Edibles & Treats
Capsules & Softgels
Topicals
By Animal Type
Dogs
Cats
Horses
Other Small Pets
By Indication
Anxiety & Stress Management
Pain & Inflammation Relief
Epilepsy & Seizure Control
General Wellness & Skin Care
By Distribution Channel
Online
Pet Specialty Stores
Veterinary Clinics & Hospital Pharmacies
Retail Pharmacies & Supermarkets

Top Companies in CBD Pet Industry

Honest Paws
Canna-Pet
Pet Releaf
HolistaPet
Charlotte's Web (Paw Choice)
cbdMD, Inc. (Paw CBD)
Canopy Growth Corporation (Martha Stewart CBD for Pets)
Wet Noses
Joy Organics
Fomo Bones

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025